[1] CENTER M M,JEMAL A,LORTET-TIEULENT J,et al.International variation in prostate cancer incidence and mortality rates[J].Eur Urol,2012,61(6):1079-1092.
[2] SIEGEL R,MA J,ZOU Z,et al.Cancer statistics,2014[J].CA Cancer J Clin,2014,64(1):9-29.
[3] MORAN V A,PERERA R J,KHALIL A M.Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs[J].Nucleic Acids Res,2012,40(14):6391-6400.
[4] CHEN L L,CARMICHAEL G G.Long noncoding RNAs in mammalian cells:what,where,and why[J].Wiley Interdiscip Rev RNA,2010,1(1):2-21.
[5] GRASSO C S,WU Y M,ROBINSON D R,et al.The mutational landscape of lethal castration-resistant prostate cancer[J].Nature,2012,487(7406):239-243.
[6] YU W,GIUS D,ONYANGO P,et al.Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA[J].Nature,2008,451(7175):202-206.
[7] 卢凯,许斌,陈恕求,等.miR-19a对于去势抵抗性前列腺癌细胞的增殖及凋亡的调控[J].现代医学,2013,41(9):613-616.
[8] 刘宁,陈明,陈恕求.P504S/AMACR在前列腺癌患者血清中的表达及其意义[J].现代医学,2010,38(3):266-268.
[9] HE J H,ZHANG J Z,HAN Z P,et al.Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells[J].J Exp Clin Cancer Res,2014,33:72.
[10] MOURTADA-MAARABOUNI M,PICKARD M R,HEDGE V L,et al.GAS5,a non-protein-coding RNA,controls apoptosis and is downregulated in breast cancer[J].Oncogene,2009,28(2):195-208.
[11] ROMANUIK T L,WANG G,MOROZOVA O,et al.LNCaP Atlas:gene expression associated with in vivo progression to castration-recurrent prostate cancer[J].BMC Med Genomics,2010,3:43.
[12] PICKARD M R,MOURTADA-MAARABOUNI M,WILLIAMS G T.Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines[J].Biochim Biophys Acta,2013,1832(10):1613-1623.
[13] YACQUB-USMAN K,PICKARD M R,WILLIAMS G T.Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells[J].Prostate,2015,75(7):693-705.
[14] PRENSNER J R,IYER M K,BALBIN O A,et al.Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1,an unannotated lincRNA implicated in disease progression[J].Nat Biotechnol,2011,29(8):742-749.
[15] PRENSNER J R,CHEN W,IYER M K,et al.PCAT-1,a long noncoding RNA,regulates BRCA2 and controls homologous recombination in cancer[J].Cancer Res,2014,74(6):1651-1660.
[16] PRENSNER J R,CHEN W,HAN S,et al.The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc[J].Neoplasia,2014,16(11):900-908.
[17] YLIPÄÄ A,KIVINUMMI K,KOHVAKKA A,et al.Transcriptome sequencing reveals PCAT5 as a novel ERG-regulated long noncoding RNA in prostate cancer[J].Cancer Res,2015,75(19):4026-4031.
[18] CREA F,WATAHIKI A,QUAGLIATA L,et al.Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer[J].Oncotarget,2014,5(3):764-774.
[19] MALIK R,PATEL L,PRENSNER J R,et al.The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer[J].Mol Cancer Res,2014,12(8):1081-1087.
[20] CHUNG S,NAKAGAWA H,UEMURA M,et al.Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility[J].Cancer Sci,2011,102(1):245-252.
[21] WANG L,SHI S,WANG L,et al.Role of PRNCR1 in the castration resistant prostate cancer[J].细胞与分子免疫学杂志,2013,29(8):789-793.
[22] YANG L,LIN C,JIN C,et al.lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs[J].Nature,2013,500(7464):598-602.
[23] REN S,LIU Y,XU W,et al.Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer[J].J Urol,2013,190(6):2278-2287.
[24] CHAKRAVARTY D,SBONER A,NAIR S S,et al.The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer[J].Nat Commun,2014,5:5383.
[25] CUI Z,REN S,LU J,et al.The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor[J].Urol Oncol,2013,31(7):1117-1123.
[26] CHIYOMARU T,YAMAMURA S,FUKUHARA S,et al.Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR[J].PLoS One,2013,8(8):e70372.
[27] ZHANG A,ZHAO J C,KIM J,et al.LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer[J].Cell Rep,2015,13(1):209-221.
[28] PRENSNER J R,IYER M K,SAHU A,et al.The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex[J].Nat Genet,2013,45(11):1392-1398.
[29] MEHRA R,SHI Y,UDAGER A M,et al.A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer[J].Neoplasia,2014,16(12):1121-1127.
[30] ZHU M,CHEN Q,LIU X,et al.lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI[J].FEBS J,2014,281(16):3766-3775.
[31] WANG L,HAN S,JIN G,et al.Linc00963:a novel,long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence[J].Int J Oncol,2014,44(6):2041-2049.
[32] LUO G,WANG M,WU X,et al.Long non-coding RNA MEG3 inhibits cell proliferation and induces apoptosis in prostate cancer[J].Cell Physiol Biochem,2015,37(6):2209-2220.
[33] WANG H,GAO X,LU X,et al.The mitotic regulator Hec1 is a critical modulator of prostate cancer through the long non-coding RNA BX647187 in vitro[J].Biosci Rep,2015,35(6):e00273.
[34] VLAEMINCK-GUILLEM V,DEVONEC M,CHAMPETIER D,et al.Urinary PCA3 to predict prostate cancer in a cohort of 1015 patients[J].Prog Urol,2015,25(16):e1-8.
[35] HENDRIKS R J,DIJKSTRA S,JANNINK S A,et al.Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine,urinary sediments and exosomes[J].Clin Chem Lab Med,2016,54(3):483-492.
[36] REN S,WANG F,SHEN J,et al.Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer[J].Eur J Cancer,2013,49(13):2949-2959.
[37] WANG F,REN S,CHEN R,et al.Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer[J].Oncotarget,2014,5(22):11091-11102.
[38] ISIN M,UYSALER E,OZGUR E,et al.Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease[J].Front Genet,2015,6:168.
[39] ZHANG W,REN S C,SHI X L,et al.A novel urinary long non-coding RNA transcript improves diagnostic accuracy in patients undergoing prostate biopsy[J].Prostate,2015,75(6):653-661. |
